Investment House LLC Sells 4,939 Shares of Danaher Corporation $DHR

Investment House LLC decreased its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 75.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,596 shares of the conglomerate’s stock after selling 4,939 shares during the quarter. Investment House LLC’s holdings in Danaher were worth $316,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Ceredex Value Advisors LLC boosted its holdings in shares of Danaher by 1.6% during the 2nd quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock worth $49,262,000 after buying an additional 3,862 shares in the last quarter. Chicago Capital LLC grew its holdings in Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares during the period. Weitz Investment Management Inc. increased its stake in Danaher by 6.1% in the second quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock valued at $104,094,000 after purchasing an additional 30,300 shares in the last quarter. Nvwm LLC boosted its position in shares of Danaher by 20.4% during the 2nd quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock worth $1,401,000 after purchasing an additional 1,204 shares in the last quarter. Finally, ASR Vermogensbeheer N.V. grew its stake in shares of Danaher by 1.9% in the 2nd quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock valued at $63,787,000 after buying an additional 6,136 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DHR shares. Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a report on Thursday, December 18th. Jefferies Financial Group upped their target price on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Leerink Partners lifted their price target on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Twenty research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $252.09.

Check Out Our Latest Stock Analysis on DHR

Danaher Price Performance

Danaher stock opened at $234.91 on Monday. The company’s 50 day moving average price is $230.26 and its two-hundred day moving average price is $213.26. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The stock has a market cap of $165.93 billion, a P/E ratio of 48.43, a P/E/G ratio of 3.58 and a beta of 0.89.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is 26.39%.

Insider Activity

In other news, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Teri List sold 3,298 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 30,248 shares of company stock valued at $6,609,663 in the last three months. Company insiders own 11.20% of the company’s stock.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.